Urology Devices Market By Product Type (Dialysis Devices, Lithotripsy & Laser Devices, Endoscopes, Accessories, and Other Devices), By Application (Urolithiasis, Bladder Disorders, Kidney Diseases, Urethral Malignancies, and Other Applications), By End-user (Dialysis Centers, Hospitals & Ambulatory Surgical Centers, and Other End-Users), By Region and Companies - Industry Segment  Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Market Overview

The Global Urology Devices Market size is expected to be worth around USD 67.7 Billion by 2033 from USD 38.5 Billion in 2023, growing at a CAGR of 5.8% during the forecast period from 2024 to 2033.

Urology devices are used to help treat and diagnose disorders such as bladder disorders, urethral malignancies, kidney disorders, and urolithiasis. These devices include catheters, sheaths, and dilators. Global urology devices market expansion is accredited to the rising presence of chronic kidney disorders, bladder cancer, and kidney stones. Furthermore, technological progress for the one-time use of cystoscopies and the increasing number of mergers and acquisitions by key players in the market raise the market expansion.

Urology devices encompass an assortment of equipment that includes catheters, urinary drainage systems, endoscopes, lithotripters (used to break down kidney stones) and prosthetic devices like urinary sphincters and penile implants. Urology devices play an integral part in diagnosing and managing conditions like urinary incontinence, kidney stones, urinary tract infections, prostate disorders as well as various forms of cancers.

Key Takeaways

• Market Size: Urology Devices Market size is expected to be worth around USD 67.7 Billion by 2033 from USD 38.5 Billion in 2023
• Market Growth: The market growing at a CAGR of 5.8% during the forecast period from 2024 to 2033.
• Product Analysis: The accessories segment is the most lucrative in the global urology devices market dominate 42.4% market share.
• Application Analysis: The kidney diseases segment is accounted 39.5% share in the global urology devices market.
• End user Analysis: The hospitals & ambulatory surgical centers segment is dominate 59.8% share in 2023.
• Geographical Analysis: North America dominate 33.7% share and and held USD 12.9 billion market revenue
• Rising Kidney Disorders: Increasing cases of kidney failures and chronic diseases drive demand for urology devices.

Product Analysis

Based on product, the market for urology devices is segmented into dialysis devices, lithotripsy & laser devices, endoscopes, accessories, and other devices. Among these products, the accessories segment is the most lucrative in the global urology devices market dominate 42.4% market share and is anticipated to increase in the forecast period. Owing to its launch of various accessories for urologic by different market key players.

Moreover, the rise in patients who visit urology clinics increases the demand for catheters & dilators in urology clinics for diagnostics and treatment purposes. The endoscope segment is anticipated to rise exponentially in the forecast period because the rising market share is due to the rising presence of urolithiasis, with a high need for disposable cystoscopies in developed countries.

Application Analysis

By application, the urology devices market is further divided into urolithiasis, bladder disorders, kidney diseases, urethral malignancies, and others. The kidney diseases segment is accounted 39.5% share in the global urology devices market. The kidney diseases segment is accredited to the rising dominance of last-stage disorders of the kidney and the increasing need for dialysis approaches and less invasive surgeries.

Bladder disorder is anticipated to grow considerably in the forecast period from 2023 to 2032. This growth is attributed to a rise in geriatric individuals affected more by diabetes, urinary tract infection, and bladder infection. Furthermore, increasing demand for urological disorders in hospitals & ambulatory centers is anticipated to grow during the forecast period.

End-User Analysis

Based on end-user, the urology devices market is segmented into dialysis centers, hospitals & ambulatory surgical centers, and others. Among these end-users, the hospitals & ambulatory surgical centers segment is dominate 59.8% share in the global urology devices market. Owing to its rising number of patient individuals who have urological disorders.

Furthermore, the rising use of urology endoscopes like ureter scopes and cystoscopy devices for diagnosis and treatment in hospitals is anticipated to increase growth in the forecast period. Dialysis centers are anticipated to grow considerably due to the rise in patients’ disorders related to kidney failures. Furthermore, increasing dialysis awareness and the concentration of market players further help the market growth.

Key Market Segments

Based on Product

• Dialysis Devices
• Lithotripsy & Laser Devices
• Endoscopes
• Accessories
• Other Devices

Based on Application

• Urolithiasis
• Bladder Disorders
• Kidney Diseases
• Urethral Malignancies
• Others

Based on End-User

• Dialysis Centers
• Hospitals & Ambulatory Surgical Centers
• Others

Drivers

Increasing Occurrence of Kidney Disorders Like Kidney Failures and Chronic Kidney Diseases

The increasing occurrence of kidney disorders like kidney failures and chronic kidney diseases are the main factors for the rise in the prevalence of dialysis in the world. Furthermore, the increasing number of patients for dialysis treatment gives an increase in the need for dialysis products akin to hemodialysis and dialysate machines. Hence, the summarized increase in market growth is mainly by manufacturers launching new equipment for urology.

These novel products with increased dominance of kidney diseases are anticipated to rise in patients and individuals who seek treatment such as dialysis, helping overall market growth. The rising dominance of different urology diseases like chronic diseases, end-stage renal diseases, urethral malignancies, and urolithiasis has appealing healthcare manufacturers and providers to help R&D for advanced technology of urology devices.

Restraints

High Cost of Urology Devices is Barrier to Market Growth

Cystoscopies like infections, urinary retention, bladder perforation, and bleeding have reduced the dominance of market devices of urology. Moreover, the sky-high cost of urology devices is a barrier to market growth.

Different authorities and governments are increasing awareness among individuals for urology facilities of health care and its related side effects due to the use of related devices. Hence, such urological devices are obstacles to market growth in the anticipated period.

Opportunities

Novel Technology to Diagnose and Treat Different Types of Kidney Diseases

Technology such as super pulsed thulium fiber laser can decrease kidney stones to tiny sizes to easily flush out from the body. Hence, such research may increase the market during the forecast period.

Other than healthcare providers, many nephrologists and manufacturers have developed novel technology to diagnose and treat different types of kidney diseases. Technology product advancement can help for better durability and visualization, increasing the prevalence of urology devices in the global market.

Trends

Various Manufacturers to Surge Their Clinical Research and Development for Disposable Cystoscopies

Diverse advantages of a one-time use of flexible cystoscopies have decreased infection spreading and quality products with no demand for repairs. Furthermore, increasing awareness of the advantages of a one-time use of cystoscopies encourages manufacturers to surge their clinical research and development for disposable cystoscopies.

Furthermore, in the forecast period, various market key players have obtained government authority’s clearance to sell cystoscopy for single use in the urology devices market.

Regional Analysis

North America is estimated to be the Most Lucrative Market

North America is estimated to be the most lucrative market in the global urology devices market, with the largest market share of 33.7% and and held USD 12.9 billion market revenue. Owing to its rising number of patients who are infected with kidney diseases visit urologists for diagnosis and treatment.

Furthermore, the rise in the prevalence of one-time use of cystoscopy and the increase in novel launches of advanced technology of urology devices by key market players are anticipated to increase market growth in this specific region. Europe has less market share compared to North America still expected to grow with a high CAGR in the forecast period. Owing to the growth of a number of patients related to urology disorders, urolithiasis, and bladder disorders.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Emerging key players are focused on various strategic policies to develop their respective businesses in foreign markets. These strategies are launching new products, contract agreements, acquisitions & mergers, collaborations, and a rise in investments. Key players dominate spending on development and research to enlarge product lines. These will increase the market to grow in the forecast period. The primary key strategy is increasing investment in the R&D sector to improve solutions for urology devices.

Market Key Players

• Terumo Corporation
• Teleflex Inc.
• Stryker
• Bard
• Olympus Corporation
• Nxstage Medical Inc.
• Nipro Corporation
• Medtronic
• KARL STORZ GmbH & Co. KG
• Hollister Incorporated
• Fresenius Medical Care AG & Co. KGaA
• Dornier MedTech
• Cook Group
• ConvaTec Group
• Coloplast
• R. Bard Inc.
• Boston Scientific Corporation
• Baxter
• Braun AG
• Asahi Kasei Corp.
• Other Key Players

Recent Developments

• In August 2024: Venture Capital Fund Establishment, Terumo Corporation launched a new corporate venture capital (CVC) fund named “Terumo Ventures,” with an allocation of $75 million. This fund is designed to enhance Terumo’s position in healthcare by investing in early-stage companies focusing on cardiovascular disease treatment, chronic disease management, and digital technologies. The initiative is part of Terumo’s broader strategy to transition from medical devices to holistic healthcare solutions, fostering innovation through strategic investments.
• In July 2023: Teleflex Inc. finalized its acquisition of Palette Life Sciences, a deal valued at approximately $650 million. This acquisition includes an upfront cash payment of $600 million and up to an additional $50 million based on achieving specific commercial milestones. Palette Life Sciences is known for products like Barrigel®, a biodegradable sculptable rectal spacer that enhances radiation treatment precision for prostate cancer patients by protecting the rectum and improving tumor control and patient quality of life. The acquisition is anticipated to add $56 million in net sales for 2023 and is expected to contribute to revenue growth in the high-teens to low 20% range for Teleflex in 2024​.
• In July 2024: Stryker completed the acquisition of Artelon, Inc., a company specializing in soft tissue fixation. This acquisition was part of Stryker’s strategy to expand its sports medicine offerings, particularly enhancing options for foot, ankle, and sports medicine surgeries. Artelon’s technology is noted for over 60,000 implantations worldwide, designed to improve biological and mechanical ligament and tendon reconstruction​.
• In April 2024: Olympus received FDA clearance for its RenaFlex single-use ureteroscope system, designed to enhance diagnostic and therapeutic procedures in the urinary tract. This system provides improved access and visualization, which is essential for treating conditions like kidney stones. Following this, in September 2024, Olympus introduced a new 4K camera head, CH-S700-08-LB, for endoscopic urology procedures, offering high-resolution imaging to support accurate diagnosis and treatment.

Report Scope